Changes
/* Historic Sales */
* The Acne Treatment Manufacturing OTC industry has maintained strong growth during the past five years. From 2007 to 2012, revenue has grown unabated, and it is expected to expand at an average annual rate of 2.4% to $2.3 billion.
* Because acne-prone individuals consider treatment products a necessary expense, revenue continued to rise during the recession, though growth did slow as consumers switched to more inexpensive products. In addition, the increasing * Increasing prevalence of adult-onset and persistent acne conditions has given rise to new, targeted products and an expanded consumer base, another factor that has aided revenue growth during the period.
* . In 2012, industry revenue is expected to maintain its growth, gaining 2.7% during the year, due to modest improvements in per capita disposable income.
The sales figures are for Mass Channel (Mass channel includes mainstream supermarkets, chain drugstores and mass merchandisers)
